Erratum: CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines
Erratum to: Transl Cancer Res 2021;10:65-72.
In the published article entitled “CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines” (Transl Cancer Res 2021;10:65-72; doi: 10.21037/tcr-19-2910) (1), Figure 5 was published incorrectly. The updated version of Figure 5 is provided below. The authors apologize for any inconvenience that this may have caused.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Shi J, Zhao H, Lian H, et al. CD276 (B7H3) improve cancer stem cells formation in cervical carcinoma cell lines. Transl Cancer Res 2021;10:65-72. [Crossref] [PubMed]
